• Substance P: High-Purity Tachykinin Neuropeptide for CNS Res

  2026-05-07

  Substance P is a tachykinin neuropeptide with verified roles in pain transmission and inflammation. APExBIO’s B6620 offers ≥98% purity and exceptional water solubility, facilitating reproducible pain transmission research. Its precise mechanism via neurokinin-1 receptor binding is foundational for immune response modulation studies.

• SIRT4 Regulation of Glutamine Metabolism Attenuates Liver Fi

  2026-05-07

  This study demonstrates that SIRT4 downregulation in hepatic stellate cells (HSCs) contributes to liver fibrosis by permitting unchecked glutamine metabolism. Restoration of SIRT4 levels or pharmacological inhibition of glutamate dehydrogenase (GDH) reduces HSC proliferation and fibrosis, highlighting a promising metabolic target for chronic liver disease intervention.

• TMEM16F Lipid Scrambling Suppresses Ferroptosis and Boosts I

  2026-05-06

  Yang et al. reveal that TMEM16F-mediated lipid scrambling acts as a late-stage suppressor of ferroptosis by remodeling plasma membrane phospholipids, thereby limiting membrane damage and lytic cell death. The study also demonstrates that inhibiting this process sensitizes tumors to ferroptosis and enhances immune rejection, providing a mechanistic basis for new cancer immunotherapy strategies.

• LDN-193189: Strategic BMP Pathway Modulation in Translation

  2026-05-06

  Explore the mechanistic and translational power of LDN-193189, a highly selective ALK inhibitor, in modulating BMP signaling for stem cell plasticity, epithelial barrier research, and disease modeling. This article bridges evidence from foundational studies and competitive market insights to offer actionable guidance for translational researchers.

• Affinity-Purified Goat Anti-Rabbit IgG (H+L) for Enhanced Im

  2026-05-05

  Leverage the Affinity-Purified Goat Anti-Rabbit IgG (H+L), Horseradish Peroxidase Conjugated Secondary Antibody from APExBIO to maximize signal amplification, reproducibility, and sensitivity in Western blot, ELISA, and IHC workflows. Discover protocol optimizations, troubleshooting insights, and practical lessons inspired by cutting-edge apoptosis research.

• AZD2461 in Precision Oncology: Dissecting Response Metrics a

  2026-05-05

  Explore how the novel PARP inhibitor AZD2461 shapes breast cancer research by targeting DNA repair and overcoming resistance. This article uniquely examines the distinction between cell viability metrics and their impact on experimental design.

• ATM Inhibition Promotes Macropinocytosis and Metabolic Adapt

  2026-05-04

  Huang et al. (2023) reveal that ATM kinase inhibition in cancer cells induces macropinocytosis, promoting survival in nutrient-poor environments. This mechanistic insight uncovers a metabolic vulnerability and suggests combinatorial strategies for targeting ATM-inhibited tumors.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-05-04

  Schwartz's dissertation advances how in vitro drug responses are quantified by dissecting the distinct contributions of proliferative arrest and cell death. This nuanced approach offers a more precise foundation for evaluating agents such as novel PARP inhibitors, with significant implications for translational breast cancer research.

• Latrunculin B Inhibitor: Precision Tool for Actin Dynamics R

  2026-05-03

  Latrunculin B offers rapid, tunable disruption of actin filaments, making it ideal for time-sensitive studies on cytoskeletal organization. Its reversible, transient inhibition enables high-resolution interrogation of actin-dependent processes, as demonstrated by advanced assay workflows and validated by recent cross-domain virology research.

• AZD0156: Advanced ATM Kinase Inhibitor Workflows in Cancer R

  2026-05-02

  AZD0156 empowers researchers to dissect the DNA damage response with unmatched selectivity, transforming DNA double-strand break repair studies and combinatorial cancer therapy models. This guide delivers protocol insights, troubleshooting, and comparative workflow strategies for maximizing the impact of this potent ATM kinase inhibitor.

• Targeted Biosynthetic Streamlining of Bitespiramycin via 3-O

  2026-05-01

  This study demonstrates the rational engineering of Streptomyces spiramyceticus to produce a simplified bitespiramycin preparation by in-frame partial deletion of the sspA 3-O-acyltransferase gene. The resulting strain yields mainly 400-isovalerylspiramycin I, reducing product complexity and facilitating downstream antibiotic research.

• Tin Mesoporphyrin IX (chloride): Precision Inhibition of Hem

  2026-05-01

  Explore how Tin Mesoporphyrin IX (chloride) enables mechanistic dissection of heme oxygenase pathways in metabolic and viral research models. This in-depth analysis reveals new cross-domain insights, bridging metabolic disease and virology for advanced experimental design.

• Cinoxacin in Quantitative Bactericidal Assays: Precision, Ki

  2026-04-30

  Explore Cinoxacin's unique role as a quinolone antibiotic in quantitative bactericidal assays and kinetic studies of Gram-negative bacteria. This article offers new assay design insights and practical guidance not found in existing resources.

• Scenario-Driven Solutions with AZD0156 for Reliable DDR Assa

  2026-04-30

  This article delivers scenario-based guidance for implementing AZD0156 (SKU B7822) in DNA damage response research. We address real laboratory challenges—assay variability, specificity pitfalls, optimization hurdles, and vendor reliability—grounding every claim in evidence or best-practice rationale. Discover how AZD0156, as supplied by APExBIO, enhances reproducibility and experimental confidence.

• L-Glutathione Reduced: Strategic Redox Insights for Translat

  2026-04-29

  Explore the mechanistic power of L-Glutathione Reduced in redox-driven cancer research, with a focus on pancreatic ductal adenocarcinoma metabolism, translational protocol refinement, and competitive positioning in the emerging antioxidant landscape. This thought-leadership article bridges rigorous evidence with actionable guidance for translational scientists.

15302 records 4/1021 page Previous Next 12345 下5页 Last page